Clinical Trial Details

EORTC-20981

Back to Clinical Trials Database

Intergroup Collaborative Study (EORTC 20981) "Rituximab (Mabthera*) in remission induction and maintenance treatment of relapsed / resistant follicular non-Hodgkin's lymphoma : a phase III randomized clinical trial" lymphoma : a phase III randomised clinical trial - Intergroup Collaborative Study (EORTC 20981) Including Amenmdment 4 (28.6.2000)

Study documentation Publications

Trial Status All trial activities ended
Dates Date of activation: 21-May-1999
Date Step1 close: 26-Apr-2004
Date Step2 close: 09-Dec-2005
Data management at EORTC Yes
Design Phase 3
Randomized open
Targeted Sample size EORTC Groups: 752
Treatment Cyclophosphamide, Doxorubicin, Prednisone, Rituximab, Vincristine
Study Staff
Type of cancer
Participating groups EORTC Lymphoma Group
Australasian Leukaemia and Lymphoma Group
Hemato-Oncologie Volwassenen Nederland
NCIC Clinical Trial Group
Nordic Lymphoma Group
Schweizerisches Arbeitsgemeinschaft Klin. Krebsforschung
South African Non-Hodgkin Lymphoma Clinical Trials Group
Participating centers
Protocol summary http://clinicaltrials.gov/ct/show/NCT00004179
NCT number NCT00004179